GUEST CONTRIBUTOR: Mark Pankuch, PhD, DABR, FAAPM Director of Medical Physics Northwestern Medicine - Central DuPage Hospital On January 1, 2024, Illinois saw the…
Building on the groundwork laid in previous years, NAPT continued its aggressive federal advocacy this year. Consistent with NAPT’s mission, its efforts centered on increasing awareness of and support for…
Virginia Attorney General Jason S. Miyares in December issued an opinion confirming that insurers in the Commonwealth are prohibited from denying coverage for proton therapy for cancer treatment when the…
Cancer is a disease where the passage of time can make a difference in treatment outcomes. Recent research underscores the reality that for cancer patients, each week of delay in…
Esophageal cancer incidence in the United States has been on the rise over the past few decades. The American Cancer Society's statistics reveal that in 2022, there were an estimated…
The recent ProPublica article, "Big Insurance Met Its Match When It Turned Down a Top Trial Lawyer’s Request for Cancer Treatment," sheds light on the issue of insurance denials for…
The National Association for Proton Therapy celebrates Coach Ron's remarkable journey, from proton therapy patient to being awarded the prestigious CSC Founders Award for his commitment to making a difference…
Explore the most recent data on proton therapy. While the 2023 NAPT Member Survey is exclusive to NAPT members, to ensure that critical industry insights reach a wider audience an…
In early 2023, the National Cancer Institute (NCI) in partnership with the U.S. Department of Health and Human Services (HHS) released the National Cancer Plan, a guide the nation’s…
Proton therapy's precision, reduced side effects, and enhanced outcomes make it an ideal option for the treatment of many types of cancer. By providing equitable access to advanced treatments like…
